Atropine –Jayson Injection^®

Atropine Sulphate
ANTI-MUSCARINIC /ANTISPASMODICS

 

COMPOSITION
Atropine®-Jayson Inj. : Each mL contains
Atropine Sulphate BP 0.6 mg.
INDICATIONS

• Cardiovascular disorders
  It is used in a variety of disorders or circumstances
  in which bradyarrhythmias occur. It is frequently
  used in sudden onset bradyarrhythmias and
  although it may also be employed for the initial
  treatment of chronic arrhythmias, cardiac pacing
  is generally preferred for long-term control.
  Examples of acute use include the prevention and
  treatment of arrhythmias associated with
  anaesthesia, the treatment of other drug-induced
  arrhythmias, and in cardiac arrest due to asystole.
  It has been used in the management of bradycardia
  of acute myocardial infarction; however,
  caution is required, as it may exacerbate
  ischaemia or infarction in these patients.
• Anaesthetic premedication
  It is given before the induction of general
  anaesthesia to diminish the risk of vagal inhibition
  of the heart and to reduce the salivary and
  bronchial secretions.
• Anticholinesterase and mushroom poisoning
• For control of muscarinic side-effects of neostigmine
  in reversal of competitive neuromuscular block

PACKAGING
Atropine®-Jayson Inj. : Box containing
10 x 1 mL Ampoules &
10 x 30 mL Vials